Shopping Cart 0
Cart Subtotal
USD 0

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 1995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 3990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 5985

Details

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland

 

Summary

 

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

 

Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from USD 2.50 billion in 2010 to USD 2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach USD 2.65 billion in 2022. However, the market value in terms of Euros was EUR1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach EUR2.80 billion in 2022. The Finnish medical device market was valued at USD 0.99 billion in 2010, which increased to USD 1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.

 

Scope

 

The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland

- Porter's five forces analysis for pharmaceutical and medical devices market of Finland

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Finnish healthcare market.

 

Reasons to buy

 

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market.

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Deals Analysis

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix


List Of Figure

List of Figures

Figure 1: Pharmaceutical Market, Finland, Revenue, 2010-2017 8

Figure 2: Medical Device Market, Finland, Revenue, 2010-2017 8

Figure 3: Total Generics Sales (by value), Finland, (%), 2015 8

Figure 4: Number of Deals (2017-2018) 12

Figure 5: 2017-2018 Deal Overview By Region 12

Figure 6: Country Profile, Finland, 2018 14

Figure 7: Pharmaceutical Market, Finland, Revenue, 2010-2017 16

Figure 8: Pharmaceutical Market, Finland, Revenue Forecast, 2018-2022 16

Figure 9: Pharmaceutical Market, Finland, Pharmaceutical Exports 17

Figure 10: Pharmaceutical Market, Finland, Top Export Partners 17

Figure 11: Pharmaceutical Market, Finland, Pharmaceutical Imports 18

Figure 12: Pharmaceutical Market, Finland, Top Import Partners 18

Figure 13: Pharmaceutical Market, Finland, Supply Channels 19

Figure 14: Pharmaceutical Market, Finland, Supply Channels, Pharmacies 19

Figure 15: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21

Figure 16: Pharmaceutical Market, Finland, Major Players 23

Figure 17: Medical Device Market, Finland, Revenue, 2010-2017 40

Figure 18: Medical Device Market, Finland, Revenue Forecast, 2018-2022 40

Figure 19: Medical Device Market, Finland, Revenue by Segment, 2017 41

Figure 20: Cardiovascular Market, Finland, Revenue 42

Figure 21: Cardiovascular Market, Finland, Market Share of Major Players 42

Figure 22: Diabetes Care Devices Market, Finland, Revenue 43

Figure 23: Diabetes Care Devices Market, Finland, Market Share of Major Players 43

Figure 24: In Vitro Diagnostics Devices Market, Finland, Revenue 44

Figure 25: In Vitro Diagnostics Devices Market, Finland, Market Share of Major Players 44

Figure 26: Orthopedic Devices, Finland, Revenue 45

Figure 27: Orthopedic Devices, Finland, Market Share of Major Players 45

Figure 28: Ophthalmic Devices Market, Finland, Revenue 46

Figure 29: Ophthalmic Devices Market, Finland, Market Share of Major Players 46

Figure 30: Diagnostic Market, Finland, Revenue (USD bn), 2010-2017 47

Figure 31: Diagnostic Market, Finland, Revenue Forecast (USD bn), 2018-2022 47

Figure 32: Medical Device Market, Finland, Revenue of Major Players 49

Figure 33: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2017-2018 69

Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Finland, 2017 69

Figure 35: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Finland, 2017-2018 69

Figure 36: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Finland, 2017-2018 70

Figure 37: Top Five Therapy Area by Deal number, Pharmaceutical Market, Finland, 2017-2018 70

Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Finland, 2017-2018 70

Figure 39: Medical Device Market Deals, Finland, 2017-2018 (by deal value, USD m) 71

Figure 40: Medical Device Market Deals, Finland, 2017-2018 (by deal count) 71

Figure 41: Medical Device Market Deals Share (by deal count), Finland, 2017-2018 71

Figure 42: Medical Device Market Deals Share (by deal value), Finland, 2017-2018 71

Figure 43: Top Therapy Area by Deal Value, Medical Device, Finland, 2017-2018 72

Figure 44: Top Therapy Area by Deal Number, Medical Device, Finland, 2017-2018 72

Figure 45: M&A Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72

Figure 46: Venture Financing Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72

Figure 47: Private Equity Deals by Therapy Area, Medical Device Finland, 2017-2018 (by value and by number) 72

Figure 48: Healthcare System, Finland 77

Figure 49: Reimbursement Process, Finland 79

Figure 50: Medical Reimbursement System, Finland 80

Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 84

Figure 52: Annual Rate of Change (%), Health Price Index, Finland 84

Figure 53: FIMEA, Organizational Structure, Finland 87

Figure 54: Life Cycle of Outpatient Medicine, Finland 89

Figure 55: Centralized Procedure, 2017, Finland 91

Figure 56: Decentralized Procedure, 2017, Finland 92

Figure 57: Mutual Recognition Procedure, 2017, Finland 93

Figure 58: Life Cycle of Medical Devices, Finland 94

Figure 59: Conformity Assessment of Class I Medical Devices, EU, 2017 96

Figure 60: Conformity Assessment of Class IIa Medical Devices, EU, 2017 97

Figure 61: Conformity Assessment of Class IIb Medical Devices, EU, 2017 98

Figure 62: Conformity Assessment of Class III Medical Devices, EU, 2017 99

Figure 63: European Patent Approval Process, EU, 2017 103

Figure 64: Unitary Patent Approval Process, EU, 2017 104

Figure 65: Trademark Approval Process, Finland, 2018 105

Figure 66: Number of Hospitals, Finland, 2010-2017 113

Figure 67: Diagnostic Equipment, Finland, 2010-2017 113

Figure 68: Hospital Beds (per 1,000 population), Finland 114

Figure 69: Acute Care Hospital Beds (per 1,000 population), Finland 114

Figure 70: Psychiatric Hospital Beds (per 1,000 population), Finland 114

Figure 71: Life Expectancy, 2010-2017, Finland 115

Figure 72: Immunization Rate (%), 2010-2017, Finland 115

Figure 73: PM2.5 (?g per m3), Finland, 2010-2016 116

Figure 74: CO Emissions (million tons), Finland, 2010-2016 116

Figure 75: Physicians (per 1,000 population), Finland, 2010-2016 117

Figure 76: Nurses (per 1,000 population), Finland, 2010-2016 117

Figure 77: Dentists (per 1,000 population), Finland, 2010-2016 117

Figure 78: Pharmacists (per 1,000 population), Finland, 2010-2016 117

Figure79: Major Causes of Mortality (per 100,000 population), Finland, 2015 118

Figure 80: Major Causes of Male Mortality, Finland, 2015 118

Figure 81: Major Causes of Female Mortality, Finland, 2015 118

Figure 82: Disability-Adjusted Life Years by Major Disease ('000), Finland, 2016 118

Figure 83: Healthcare Expenditure as Percentage of GDP (%), Finland, 2010-2017 119

Figure 84: Public-Private Share (%), Finland, 2010-2016 119

Figure 85: Major Components of Healthcare Spending (%), Finland, 2016 120

Figure 86: Opportunities and Challenges, Finland 124


List Of Table

List of Tables

Table 1: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class (USD m), 2016 21

Table 2: Pharmaceutical Market, Finland, Sales of Major Drug Categories by Major Therapeutic Class (USD m), 2016 21

Table 3: Medical Device Market, Finland, Revenue by Segment 41

Table 4: Cardiovascular Devices Market, Finland, Revenue and Market Share of Major Players 42

Table 5: Diabetes Care Devices Market, Finland, Revenue and Market Share of Major Players 43

Table 6: In Vitro Diagnostics Devices Market, Finland, Revenue and Market Share of Major Players 44

Table 7: Orthopedic Devices Market, Finland, Revenue and Market Share of Major Players 45

Table 8: Ophthalmic Devices Market, Finland, Revenue and Market Share of Major Players 46

Table 9: Reimbursement for Medical Expenses, Finland 79

Table 10: Exceptional Copayment Rate for Specific Medicines, Finland 80

Table 11: Market Authorization Fees, 2017, Finland 90

Table 12: Patent Fees, 2017, Finland 102

Table 13: Pharmacy Tax for a Pharmacy Owning a Subsidiary Pharmacy 109

Table 14: Package Label Information, Finland, 2017 110

Table 15: Trade Associations, Finland 121

Table 16: Trade Fairs, Finland 122

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Finland, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Deals, Porter Five Forces,Opportunities and Challenges

Company Profile

Company Profile Title

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland

 

Summary

 

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

 

Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from USD 2.50 billion in 2010 to USD 2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach USD 2.65 billion in 2022. However, the market value in terms of Euros was EUR1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach EUR2.80 billion in 2022. The Finnish medical device market was valued at USD 0.99 billion in 2010, which increased to USD 1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.

 

Scope

 

The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland

- Porter's five forces analysis for pharmaceutical and medical devices market of Finland

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Finnish healthcare market.

 

Reasons to buy

 

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market.

READ MORE

Scope

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Deals Analysis

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix


List Of Figure

List of Figures

Figure 1: Pharmaceutical Market, Finland, Revenue, 2010-2017 8

Figure 2: Medical Device Market, Finland, Revenue, 2010-2017 8

Figure 3: Total Generics Sales (by value), Finland, (%), 2015 8

Figure 4: Number of Deals (2017-2018) 12

Figure 5: 2017-2018 Deal Overview By Region 12

Figure 6: Country Profile, Finland, 2018 14

Figure 7: Pharmaceutical Market, Finland, Revenue, 2010-2017 16

Figure 8: Pharmaceutical Market, Finland, Revenue Forecast, 2018-2022 16

Figure 9: Pharmaceutical Market, Finland, Pharmaceutical Exports 17

Figure 10: Pharmaceutical Market, Finland, Top Export Partners 17

Figure 11: Pharmaceutical Market, Finland, Pharmaceutical Imports 18

Figure 12: Pharmaceutical Market, Finland, Top Import Partners 18

Figure 13: Pharmaceutical Market, Finland, Supply Channels 19

Figure 14: Pharmaceutical Market, Finland, Supply Channels, Pharmacies 19

Figure 15: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21

Figure 16: Pharmaceutical Market, Finland, Major Players 23

Figure 17: Medical Device Market, Finland, Revenue, 2010-2017 40

Figure 18: Medical Device Market, Finland, Revenue Forecast, 2018-2022 40

Figure 19: Medical Device Market, Finland, Revenue by Segment, 2017 41

Figure 20: Cardiovascular Market, Finland, Revenue 42

Figure 21: Cardiovascular Market, Finland, Market Share of Major Players 42

Figure 22: Diabetes Care Devices Market, Finland, Revenue 43

Figure 23: Diabetes Care Devices Market, Finland, Market Share of Major Players 43

Figure 24: In Vitro Diagnostics Devices Market, Finland, Revenue 44

Figure 25: In Vitro Diagnostics Devices Market, Finland, Market Share of Major Players 44

Figure 26: Orthopedic Devices, Finland, Revenue 45

Figure 27: Orthopedic Devices, Finland, Market Share of Major Players 45

Figure 28: Ophthalmic Devices Market, Finland, Revenue 46

Figure 29: Ophthalmic Devices Market, Finland, Market Share of Major Players 46

Figure 30: Diagnostic Market, Finland, Revenue (USD bn), 2010-2017 47

Figure 31: Diagnostic Market, Finland, Revenue Forecast (USD bn), 2018-2022 47

Figure 32: Medical Device Market, Finland, Revenue of Major Players 49

Figure 33: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2017-2018 69

Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Finland, 2017 69

Figure 35: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Finland, 2017-2018 69

Figure 36: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Finland, 2017-2018 70

Figure 37: Top Five Therapy Area by Deal number, Pharmaceutical Market, Finland, 2017-2018 70

Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Finland, 2017-2018 70

Figure 39: Medical Device Market Deals, Finland, 2017-2018 (by deal value, USD m) 71

Figure 40: Medical Device Market Deals, Finland, 2017-2018 (by deal count) 71

Figure 41: Medical Device Market Deals Share (by deal count), Finland, 2017-2018 71

Figure 42: Medical Device Market Deals Share (by deal value), Finland, 2017-2018 71

Figure 43: Top Therapy Area by Deal Value, Medical Device, Finland, 2017-2018 72

Figure 44: Top Therapy Area by Deal Number, Medical Device, Finland, 2017-2018 72

Figure 45: M&A Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72

Figure 46: Venture Financing Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72

Figure 47: Private Equity Deals by Therapy Area, Medical Device Finland, 2017-2018 (by value and by number) 72

Figure 48: Healthcare System, Finland 77

Figure 49: Reimbursement Process, Finland 79

Figure 50: Medical Reimbursement System, Finland 80

Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 84

Figure 52: Annual Rate of Change (%), Health Price Index, Finland 84

Figure 53: FIMEA, Organizational Structure, Finland 87

Figure 54: Life Cycle of Outpatient Medicine, Finland 89

Figure 55: Centralized Procedure, 2017, Finland 91

Figure 56: Decentralized Procedure, 2017, Finland 92

Figure 57: Mutual Recognition Procedure, 2017, Finland 93

Figure 58: Life Cycle of Medical Devices, Finland 94

Figure 59: Conformity Assessment of Class I Medical Devices, EU, 2017 96

Figure 60: Conformity Assessment of Class IIa Medical Devices, EU, 2017 97

Figure 61: Conformity Assessment of Class IIb Medical Devices, EU, 2017 98

Figure 62: Conformity Assessment of Class III Medical Devices, EU, 2017 99

Figure 63: European Patent Approval Process, EU, 2017 103

Figure 64: Unitary Patent Approval Process, EU, 2017 104

Figure 65: Trademark Approval Process, Finland, 2018 105

Figure 66: Number of Hospitals, Finland, 2010-2017 113

Figure 67: Diagnostic Equipment, Finland, 2010-2017 113

Figure 68: Hospital Beds (per 1,000 population), Finland 114

Figure 69: Acute Care Hospital Beds (per 1,000 population), Finland 114

Figure 70: Psychiatric Hospital Beds (per 1,000 population), Finland 114

Figure 71: Life Expectancy, 2010-2017, Finland 115

Figure 72: Immunization Rate (%), 2010-2017, Finland 115

Figure 73: PM2.5 (?g per m3), Finland, 2010-2016 116

Figure 74: CO Emissions (million tons), Finland, 2010-2016 116

Figure 75: Physicians (per 1,000 population), Finland, 2010-2016 117

Figure 76: Nurses (per 1,000 population), Finland, 2010-2016 117

Figure 77: Dentists (per 1,000 population), Finland, 2010-2016 117

Figure 78: Pharmacists (per 1,000 population), Finland, 2010-2016 117

Figure79: Major Causes of Mortality (per 100,000 population), Finland, 2015 118

Figure 80: Major Causes of Male Mortality, Finland, 2015 118

Figure 81: Major Causes of Female Mortality, Finland, 2015 118

Figure 82: Disability-Adjusted Life Years by Major Disease ('000), Finland, 2016 118

Figure 83: Healthcare Expenditure as Percentage of GDP (%), Finland, 2010-2017 119

Figure 84: Public-Private Share (%), Finland, 2010-2016 119

Figure 85: Major Components of Healthcare Spending (%), Finland, 2016 120

Figure 86: Opportunities and Challenges, Finland 124


List Of Table

List of Tables

Table 1: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class (USD m), 2016 21

Table 2: Pharmaceutical Market, Finland, Sales of Major Drug Categories by Major Therapeutic Class (USD m), 2016 21

Table 3: Medical Device Market, Finland, Revenue by Segment 41

Table 4: Cardiovascular Devices Market, Finland, Revenue and Market Share of Major Players 42

Table 5: Diabetes Care Devices Market, Finland, Revenue and Market Share of Major Players 43

Table 6: In Vitro Diagnostics Devices Market, Finland, Revenue and Market Share of Major Players 44

Table 7: Orthopedic Devices Market, Finland, Revenue and Market Share of Major Players 45

Table 8: Ophthalmic Devices Market, Finland, Revenue and Market Share of Major Players 46

Table 9: Reimbursement for Medical Expenses, Finland 79

Table 10: Exceptional Copayment Rate for Specific Medicines, Finland 80

Table 11: Market Authorization Fees, 2017, Finland 90

Table 12: Patent Fees, 2017, Finland 102

Table 13: Pharmacy Tax for a Pharmacy Owning a Subsidiary Pharmacy 109

Table 14: Package Label Information, Finland, 2017 110

Table 15: Trade Associations, Finland 121

Table 16: Trade Fairs, Finland 122

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Finland, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Deals, Porter Five Forces,Opportunities and Challenges